Mike Evers of Orthoworld estimates that orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges are manageable.

Content republished with permission from ORTHOWORLD® Inc.

Mike Evers of Orthoworld discusses how the orthopedic market finds itself in familiar territory in early 2022, with COVID infections surging to record levels. While we await fourth-quarter and full-year results from orthopedic companies, we'll summarize below our expectations and questions for the market as it enters the third year of disruption from the pandemic.

Content republished with permission from ORTHOWORLD® Inc.

Some consider trade shows to be a necessary evil — be seen or be gone. Others see them as a great tool in their marketing kit. They are a really a combination of both. As we re-enter a more customary world of MedTech tradeshows and events, it may be useful to look at why we attend them in the first place.

Mike Evers of Orthoworld discusses how the orthopedic market outperformed expectations in the first half of 2021, given gaps in vaccine coverage and the surging delta variant.

Content republished with permission from ORTHOWORLD® Inc.

An interview with our partners Larry Barr, Göran Brorsson, and Chuck Weikel discussing the first half of 2021 in the MedTech M&A markets.

Mike Evers of Orthoworld discusses the state of Orthopedic markets and M&A in 2Q21. As we near 2Q earnings, we're watching for a barometer of the market's recovery, momentum in M&A, as well as the evolution toward digital.

Content republished with permission from ORTHOWORLD® Inc.

Early earnings previews from companies reinforce Orthoworld’s belief that the orthopedic market will decline around -10% in 2020. Below they preview some positives from the fourth quarter and the most recent COVID and U.S. jobs data, as well as some early thoughts for 2021.

Content republished with permission from ORTHOWORLD® Inc.

Our partners Larry Barr, Göran Brorsson, and Chuck Weikel sat down to discuss the state of MedTech M&A and expectations for the new year.

There is no question that there is larger distance between European markets today and anytime in recent memory. This had begun before Covid-19 with protectionist trade policies and then continued up to today, as travel restrictions and limitations on visits and shut down much M/A activity, both in Europe and North America. To understand this in greater detail, Chuck Weikel discussed with Göran Brorsson, our European Partner at Middle Branch Partners, about what he is experiencing in the European market.